Journal
AMERICAN HEART JOURNAL
Volume 162, Issue 3, Pages 412-424Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.ahj.2011.06.007
Keywords
-
Categories
Funding
- VA HSRD career scientist award [RCS 08-027]
- American Heart Association
- NIH [UL1RR024128]
Ask authors/readers for more resources
Poor adherence to efficacious cardiovascular-related medications has led to considerable morbidity, mortality, and avoidable health care costs. This article provides results of a recent think-tank meeting in which various stakeholder groups representing key experts from consumers, community health providers, the academic community, decision-making government officials (Food and Drug Administration, National Institutes of Health, etc), and industry scientists met to evaluate the current status of medication adherence and provide recommendations for improving outcomes. Below, we review the magnitude of the problem of medication adherence, prevalence, impact, and cost. We then summarize proven effective approaches and conclude with a discussion of recommendations to address this growing and significant public health issue of medication nonadherence. (Am Heart J 2011;162:412-24.)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available